Too good too pass up? CyPass Micro-Stent
- Posted on: Feb 9 2018
For patients with mild to moderate primary open-angle glaucoma considering cataract surgery, the CyPass Micro-Stent may help to reduce intraocular pressure (IOP) and decrease the patients’ dependence on glaucoma medication. Two years after CyPass treatment, 72.5% of patients still experience >20% decrease in IOP and CyPass treatment is 32% more effective at lowering IOP than stand-alone cataract surgery. The CyPass stent (like a tube) fits naturally along the anatomy of the eye where fluid filters out-increasing outflow. The surgery is minimally-invasive and is performed at the same time as cataract surgery.
Dr. Ballitch offers patients in the Mansfield, Ohio area the latest advances in eye care and glaucoma management. If you or a loved one has glaucoma, we can help! Call 419-521-3937 to get started today.
Posted in: Glaucoma